TrialEndocrine-related cancer2014

Telotristat etiprate, a novel serotonin synthesis inhibitor, in patients with carcinoid syndrome and diarrhea not adequately controlled by octreotide.

Matthew H Kulke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.